Celcuity Inc
CELC
NASDAQ
Biotechnology
$92.00
USD
+5.40 (+6.24%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $4.36B
Volume 1.3M
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
PBLS | Parabilis Medicines Inc | - | - | - | - | |
TVTX | Travere Therapeutics Inc | $5.74B | - | +77.1% | - | |
ACAD | ACADIA Pharmaceuticals Inc | $5.07B | 13.34 | +47.0% | - | |
DYN | Dyne Therapeutics, Inc | $4.95B | - | - | - | |
TNGX | Tango Therapeutics Inc | $4.51B | - | +39.0% | - | |
RLAY | Relay Therapeutics Inc | $4.37B | - | +23.9% | - | |
CELC | Celcuity Inc | $4.36B | - | - | - | |
DNLI | Denali Therapeutics Inc | $4.05B | - | - | - |
Top Peer by Growth
Legend Biotech Corp
+56.4% YoY Revenue
Lowest P/E Ratio
ACADIA Pharmaceuticals Inc
12.85x P/E
Best 1-Year Return
Relay Therapeutics Inc
+499.1% Return